EFTA01522665

CHISLAINE MAXWELL-HY ACCT. For the Period 11/1/11 to 11/30/I1 Type Quantity Settle Date Selection Method Description Cost Amount Interest Purchased 11/3 Accrued Int Paid NIELSEN FINANCE LLC/C0 7 3/4% OCT 15 2018 DID 04115/2011 110.50 MORGAN STANLEY 8 CO. INCORPORATED TRADE DATE 1W31/11 (ID: 654090-AY-8) 11/4 Accrued Int Pail NIELSEN FINANCE LLC/CO 7 3/4% OCT 15 2018 DTD 04/15/2011 O 110.25 MORGAN STANLEY 8 CO. INCORPORATED TRADE DATE 11/01/11 (ID: 654090-AY-8) 0.00 0.00 (23.25) (8.18) Total Interest Purchased ($31.43) TRADE ACTIVITY Note: S indicates Short Term Realized Gain/Loss * Settled transaction was initiated in prior statement period and settled in current statement period Trade Date Type Per Unit Realized Settle Date Selection Method Description Quantity Amount Proceeds Tax Cost Gain/Loss Settled Sales/Maturities/Redemptions 11/23 Sale CHS/COMMUNITY HEALTH SYS 87/8% JUL 15 2015 DTD (5,000.000) 101.80 5,08730 (5,433.75) (346.25) S 11/23 Pro Rata 07/25/2007 ELECTED BONDS - EXP 12/06/2011 PRORATED TENDER - HOLDERS REVEIVE $1017.50, 531.309028 IN ACCRUED INTEREST, AND S30 FOR EVERY 1,000 PA VALIDLY TENDERED AND ACCEPTED OF COMMUNITY HEALTH, CUSIP: 12543DAF7. TENDER PRORATED AT A RATE OF 0.3978807155 (ID: 12599134Z-1) J.P.Morgan Page 19 of 20 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00050232 SDNY_GM_00319430 EFTA01522665